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caspase inhibitor, equally reduced apoptosis afterABSTRACT: Insulin-like growth factor-I (IGF-
NGF withdrawal. The antiapoptotic effect of IGF-II) is emerging as an important growth factor able to
was completely blocked by LY294002, an inhibitor ofmodulate the programmed cell death (PCD) pathway
mediated by the cysteine-dependent aspartate prote- PI 3-kinase signaling, but not by the mitogen-activated
ases (caspases); however, little is known about the protein (MAP) kinase/extracellular signal-regulated
effect of IGF-I after nerve growth factor (NGF) with- protein kinase (ERK) activated protein kinase inhibi-
drawal in neurons. To begin to understand the neu- tor PD98059. Functional IGF-I receptors were exten-
ronal death-sparing effect of IGF-I under NGF-free sively expressed both in rat and human DRG neurons,
conditions, we tested whether embryonic sensory dor- although they were most abundant in the neuronal
sal root ganglion neurons (DRG) were able to survive growth cone. Collectively, these findings indicate that
in defined serum-free medium in the presence of IGF- IGF-I, signaling though the PI-3 kinase pathway, is
I. We further studied the role of IGF-I signaling and important in modulating PCD in cultured DRG neu-
caspase inhibition after NGF withdrawal. NGF with- rons after NGF withdrawal, and IGF-I may be im-
drawal produced histological changes of apoptosis in- portant in DRG embryogenesis. q 1998 John Wiley &
cluding chromatin condensation, shrinkage of the per-
Sons, Inc. J Neurobiol 36: 455–467, 1998ikaryon and nucleus, retention of the plasma mem-
Keywords: apoptosis; IGF-I; IGF-I receptor; neurons;brane, and deletion of single cells. Both IGF-I and
NGFBoc-aspartyl (OMe)-fluoromethylketone (BAF), a
Insulin-like growth factor-I (IGF-I) is a polypeptide of cloned neural cell lines (Singleton et al., 1996a;
Párrizas et al., 1997) and primary neurons (Zacken-essential for normal fetal, neonatal, and pubertal
fels and Rohrer, 1993; Zackenfels et al., 1995;growth (Daughaday and Rotwein, 1989; Zackenfels
Miller et al., 1997; Sortino and Canonico, 1996).et al., 1995). In vitro, IGF-I promotes the survival
The biological actions of IGF-I are mediated by the
type I IGF receptor (IGF-I receptor) . Like IGF-I,Correspondence to: E. L. Feldman
there is developmental and tissue specific expres-Contract grant sponsor: Veterans Administration
Contract grant sponsor: NIH; Contract grant numbers: sion of the IGF-I receptor in the nervous system
NS01938, NS14304, NS32843 (Bondy et al., 1990; Lenoir and Honegger, 1983;Contract grant sponsor: Juvenile Diabetes Foundation
van der Pal et al., 1988; Cohen et al., 1992).Contract grant sponsor: American Diabetes Foundation
q 1998 John Wiley & Sons, Inc. CCC 0022-3034/98/040455-13 In our laboratory, we are interested in the role
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Madison, WI) were aseptically plated on air-dried, colla-of IGF-I and the IGF-I receptor in the growth, sur-
gen-coated plastic dishes as previously described (Win-vival, and differentiation of neurons. Our prelimi-
debank and Blexrud, 1986; Russell et al., 1994). Explantsnary studies suggest that IGF-I promotes neuronal
were incubated at 377C with 5% carbon dioxide, in serum-survival by inhibiting programmed cell death
free defined medium (SFDM) containing Eagle’s mini-(PCD) (Matthews and Feldman, 1996; Singleton et
mal essential medium (EMEM; Gibco, Grand Island,
al., 1996a,b; Matthews et al., 1997). IGF-I rescues NY) supplemented with 1.4 mM L-glutamine, 30 mM
SH-SY5Y human neuroblastoma cells and primary glucose, 30 nM selenium, 10 nM hydrocortisone, 10 nM
dorsal root ganglia (DRG) neurons from stress in- b-estriadiol, and 100 mg/mL transferrin (Sigma Chemical
duced PCD (Matthews and Feldman, 1996; Russell Co., St. Louis, MO). We had previously observed that
and Feldman, 1996) via IGF-I:IGF-I receptor acti- this medium produces equal or superior neuronal growth
and survival between 0 and 96 h compared to mediumvation of the phosphatidyl-inositol (PI) 3-kinase
containing calf serum. Control DRG were supplementedpathway (Singleton et al., 1996a; Miller et al.,
with 10 ng/mL 2.5S NGF (Bioproducts for Science, Mad-1997). Upon PI 3-kinase activation, IGF-I signaling
ison, WI). We had previously obtained optimal DRGincreases the levels of the antiapoptotic bcl proteins
survival and neurite halo development in defined medium(Singleton et al., 1996a) while blocking activation
using this specific NGF product at this concentrationof the effectors of neural death, the cysteine-depen-
(Russell and Feldman, 1996).
dent aspartate proteases (caspases) (Singleton et al., Dissociated DRG were prepared by incubating the
1996a). whole DRG in 0.05% trypsin (Gibco) for 40 min at 377C,
In the current study, we asked whether IGF-I centrifuging at 800 1 g for 5 min, followed by trypsin
could rescue DRG neurons from PCD induced by removal. The cells were washed in EMEM, followed by
nerve growth factor (NGF) withdrawal. We chose gentle tituration through a Pasteur pipet with a flame-
narrowed tip. To reduce the number of contaminatingthe experimental paradigm of NGF withdrawal in
Schwann cells and fibroblasts, neurons were preplatedcultured DRG neurons because it provides a model
on positively charged Primaria plates (Falcon, Franklinfor looking at the role of trophic factors during de-
Lakes, NJ) for 45 min, which reduces the number ofvelopment. Neurons in the vertebrate nervous sys-
nonneuronal cells from 3% to 0.1% (Deckwerth andtem, like DRG, become dependent on neurotrophic
Johnson, 1994). The dissociated DRG neurons werefactors once they begin to innervate their targets
plated at a density of approximately 5000 neurons/colla-
(Scott and Davies, 1990). In embryonic DRG there gen-coated glass slide. To improve the quality of staining
is an increase in PCD from embryonic day 15 on- and counting, dissociated rat DRG cultures were used for
ward as target factors including NGF determine the all experiments except transmission electron microscopy
number of surviving sensory neurons (Coggeshall (TEM). For TEM, whole DRG were used to improve
et al., 1994). These sensory neurons are acutely the quality of embedding and sectioning of DRG neurons.
sensitive to growth factor withdrawal and insuffi-
cient NGF results in PCD (Deckwerth and Johnson, Histological Determination of Apoptosis
1993; Scott and Davies, 1990). We used the para-
To determine the percentage of apoptotic cells, nucleardigm of NGF withdrawal to determine what role
DNA fragments were tailed with digoxigenin-dUTPIGF-I may play in DRG embryogenesis.
(Schmitz et al., 1991) and labeled with a fluorescein
We report that both rat and human DRG express isothiocyanate (FITC) antibody as previously described
the IGF-I receptor. In vitro, IGF-I maintains DRG (Gavrieli et al., 1993). Briefly, dissociated DRG on colla-
neuronal survival after NGF withdrawal for at least gen-coated glass slides were fixed in 4% buffered forma-
72 h. The antiapoptotic effect of IGF-I is mediated lin for 10 min at room temperature, washed in phosphate-
by PI 3-kinase and mimics the effect of caspase buffered saline (PBS), and incubated with equilibration
buffer, followed by freshly prepared terminal deoxy-inhibitors such as Boc-aspartyl (OMe)-fluoro-
nucleotidyl transferase (TdT) medium in a humid holdingmethylketone (BAF). Collectively, these results
tray at 377C for 1 h. After stopping the reaction withsuggest a role for IGF-I and the IGF-I receptor in
stop/wash buffer, cells were stained with freshly preparedthe development and maintenance of DRG neurons.
anti-digoxigenin fluorescein (Oncor, Gaithersburg, MD)
diluted as per the manufacturer’s instructions, for 45 min
at room temperature. The cells were then counterstained
MATERIALS AND METHODS with 1 1 freshly prepared propidium iodide for 15 min
and mounted in Prolong (Molecular Probes, Eugene, OR)
to preserve the immunofluorescent emission. PositiveDRG Culture
controls using DNA nicked with DNAse 1, and negative
controls with water substituted for TdT were used forDorsal root ganglion neurons from 15-day-old embryonic
(E15) Sprague–Dawley rats (Harlan Sprague–Dawley, each experiment.
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neurite extensions. For electron microscopy, whole DRGTEM
were plated in test media for 48 h and then prepared for
For TEM, five to six whole DRG were cultured per dish, electron microscopy as described below. Apoptosis on
with a total of 30–40 DRG/condition. DRG were fixed TEM was not quantified; however, three thin sections
in fresh Trump’s fixative (1% glutaraldehyde and 4% separated vertically by at least 60 mm (to avoid photo-
formaldehyde in 0.1 M phosphate buffer) for a minimum graphing the same nucleus twice) were studied from each
of 2 h. Tissue was rinsed for 30 min in three changes of of the blocks.
0.15 M cacodylate buffer, pH 7.2, followed by 1 h postfix To determine if the neuroprotective effect of IGF-I in
in 1% OsO4. After rinsing in three changes of distilled neuronal survival was mediated by activation of PI 3-
water for 30 min, the tissue was en bloc stained with 2% kinase or by mitogen-activated protein (MAP)-kinase
uranyl acetate for 30 min at 607C. After en bloc staining, signaling, we studied the effect of specific inhibitors on
the tissue was rinsed once in distilled water, dehydrated apoptosis. Dissociated DRG neurons were cultured as
in progressive concentrations of ethanol, washed in 100% indicated above. Cultures were then incubated for 48 h
propylene oxide, and embedded in Spurr’s resin. Thin in control medium, medium containing no NGF, with 100
(90-nm) sections were cut, placed on 200-mm mesh cop- nM IGF-I alone, with 100 nM IGF-I and 10 mM PI 3-
per grids, and stained with lead citrate. All chemicals kinase inhibitor (LY294002), or with 100 nM IGF-I and
were obtained from Electron Microscopy Services (Ft. 10 mM MAP-kinase/extracellular signal-regulated pro-
Washington, PA). Photographs were taken with the oper- tein kinase (ERK) inhibitor (PD98059). Both LY294002
ator unaware of the treatment condition, using a Phillips and PD98059 were obtained from Biomol (Plymouth
CM100 TEM operating at 60 kV. Images were stored Meeting, PA). Cells were preincubated for 1 h with
digitally. LY294002 or PD98059, prior to addition of IGF-I.
To determine if inhibition of caspase activation would
inhibit apoptosis induced by NGF withdrawal, we used
Boc-aspartyl (OMe)-fluoromethylketone (BAF), whichEffect of NGF Withdrawal and IGF-I
generally inhibits caspases including caspase-3. DRGon Neuronal Apoptosis
neurons were cultured as indicated above and then incu-
To initiate NGF withdrawal, one of two methods was bated for 48 h in control medium, medium containing no
used. In both methods, the cultures were preplated on NGF, with 100 nM IGF-I alone, 100 mM BAF, or 100
Primaria plates to remove most of the contaminating pri- mM BAF with 100 nM IGF-I. BAF was a gift from Dr.
mary Schwann cells and fibroblasts (Deckwerth and Brenda Shiver, Parke Davis, Ann Arbor, Michigan. Previ-
Johnson, 1994). First, at the time of plating, dissociated ous experiments in our laboratory indicated the optimal
DRG neurons were cultured in SFDM alone without concentration of BAF for blocking PCD in DRG neurons
NGF, or with NGF, IGF-I, or a combination of the two. was 100 mM .
Second, DRG neurons after preplating were cultured in
SFDM, 10 ng/mL NGF, and 40 mM 5-fluoro-2* deoxyuri-
dine (FUDR)/uridine (Sigma) to ensure removal of vir- Immunohistochemistry, In Situ
tually all Schwann cells and fibroblasts. Cultures were Hybridization, and Reverse
maintained in FUDR/uridine for 5 days. The neuron rich Transcriptase–Polymerase Chain
cultures were then washed three times in EMEM and Reaction (RT-PCR)
incubated in SFDM without NGF, NGF and IGF-I, or
IGF-I alone. In cultures in which NGF was excluded, Dissociated E15 rat DRG neurons were cultured for 24
h in SFDM with 40 mM FUDR (Sigma) . After fixinganti-NGF antibody (Collaborative Biomedical Products,
Bedford, MA) in a concentration of 10 mg/mL was added in 4% paraformaldehyde and permeabilizing the neu-
rons with Triton X-100 for 15 min each, they wereto bind traces of NGF remaining after washing. Test me-
dium was changed every 24 h. IGF-I used at a concentra- incubated in 10 mg/mL of chicken IGF-IR immunoglob-
ulin Y (IgY) polyclonal Ab (Upstate Biotechnology,tion of 1–100 nM was a gift from Cephalon (West Ches-
ter, PA). For composite data analysis, results were stan- Lake Placid, NY) for 6 h, followed by 7.5 mg/mL of
goat anti-chicken secondary antibody and 50 mg/mLdardized against control conditions. To determine the
percentage of apoptotic nuclei, neurons were cultured for avidin-fluorescein (Santa Cruz Biotechnology, Santa
Cruz, CA), all at room temperature. The IGF-I receptor12–72 h in test media, photographed with a Leitz Or-
thoplan microscope, and counted by an observer blinded distribution was then visualized using a Noran Confocal
Microscope, fitted with Oz with Intervision (Noran In-to the condition using a random-order number grid system
as previously described (Russell et al., 1995). Approxi- struments, Madison, WI) .
Human DRG were obtained at autopsy between 8 andmately 5000 neurons were plated per slide, four slides
were reviewed per condition, and experiments were re- 12 h after death in patients in whom there was no evi-
dence of neuropathy or of disorders predisposing to dis-peated at least in triplicate. Only positively identified neu-
ronal nuclei on corresponding phase contrast images were ease of the DRG. The bodies had been previously cooled
within 1 h of death. For RT-PCR, total RNA was isolatedcounted to exclude potential artifactual staining. DRG
neurons have rounded, phase-bright cell bodies with clear from human adult autopsy DRG by a single-step method
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(RNA STAT-60; Tel-Test ‘‘B’’) ; RNA was quantified 1989). The tissues were washed in SSC and a series of
buffers (Boehringer Mannheim) as previously describedby spectrophotometry at 260 nm and its integrity was
(Viaene and Baert, 1995). Immunological detection oftested by formaldehyde/agarose gel electrophoresis.
the IGF-I receptor was performed by incubation of theFirst-strand cDNA was synthesized from 1 mg total RNA
tissues with an antidigoxigenin antibody at 377C for 30in a 20-mL reaction containing 5 mM MgCl2, 11 PCR
min, rewashed, and incubated in a mixture of 4-Nitrobuffer, 1 mM deoxyribonucleotide triphosphates, 2.5 mM
blue tetrazolium chloride in buffer, 5-bromo-4-chloro-3-random hexamers, 1 U/mL RNAse inhibitor, and 2.5 U/
indolylphosphate, and 125 nM levamisole. After 3 h, themL Moloney murine leukemia virus reverse transcriptase
color reaction was stopped in Tris-HCl/ethylenediamine-(Gibco BRL Life Technologies, Gaithersburg, MD).
tetraacetic acid (EDTA) buffer. Control sections werePCR was performed in a 50-mL reaction containing 10
hybridized either without labeled probe, with digoxi-mL of each of the mixtures from the RT reaction, 2 mM
genin-labeled antisense Neo RNA (Boehringer Mann-MgCl2 , 11 PCR buffer, 0.6 mM dNTPs, 0.15 mM each
heim), or with labeled sense probe.of 5* and 3 * primers, and 1.25 U/50 mL of Native Taq
DNA polymerase (Perkin-Elmer, Norwalk, CT). Ampli-
fication was performed for 30 cycles, each cycle con-
Statistical Analysissisting of 1 min denaturation at 957C, 2 min annealing at
547C, and 3 min extension at 727C; an additional exten- Assumptions about the Gaussian distribution of data were
sion time of 7 min at 727C was added at the end of the made using normalized cumulative frequency polygons
30 cycles. Primers were identified using the Right Primer and determination of the skewness and kurtosis of data.
BioDisk Software (Biodisk, San Francisco, CA). IGF-I Data not exactly corresponding to a Gaussian distribution
receptor sense and anti-sense primers (5 *-GCCTTTCA- were analyzed using an appropriate mathematical trans-
CATTGTACGCATC-3 * and 5 *-CTCCCACTCATCAG- formation, usually log (x) . Comparison of dependent
GAACGTACAC-3 *) were selected from human cDNA variables was performed using factorial analysis of vari-
sequences (GenBank accession no. M23102) (Ullrich et ance (ANOVA), and Fisher’s LSD test was used as a
al., 1986). The respective rat primers were antisense: 5*- posterior procedure for making pairwise comparisons of
GGCAGACGTCACAGAATCGATGGT-3 * and sense: means. Inference was made using a probabilityõ.05. For
5*-CATCCGCAACGACTATCAGCA-3 * (GenBank ac- graphic and descriptive purposes, data are expressed in
cession no. M27293) (Werner et al., 1989). The PCR actual units { the standard error of the mean (S.E.M.) .
products were analyzed on a 2.0% agarose gel. The speci-
ficity of the obtained band was ascertained by cloning
the PCR product (TA cloning kit; Invitrogen, San Diego,
RESULTSCA) and sequencing it with M13 forward and reverse
universal primers, by the chain termination method
IGF-I Protects Neurons from Apoptosis(Sanger et al., 1977). Primers detecting b-actin mRNA
after NGF Withdrawal(5*-CAATGCCAGGGTACATGGTGGTG-3 * and 5 *-
GGATCCGACTTCGAGCAAGAGATGGCCAC) were
When DRG neurons were cultured for 5 days inused to normalize for the amount of cDNA in each reac-
SFDM/FUDR and then NGF were withdrawn andtion.
10 mg/mL NGF antibody was added (Fig. 1) , thereAfter autopsy the human fifth lumbar DRG was re-
was an increase in the percentage of apoptotic neu-moved and then embedded in paraffin as previously de-
rons, ranging from 36.28 { 5.30% at 12 h to 99.70scribed (Dyck et al., 1986). For in situ hybridization,
{ 0.21% at 72 h. By 48 h, most of the DRG neuronsfreshly cut sections were dewaxed in xylene, then ethanol,
and then PBS. The tissue sections were immersed in 0.2 were dead (96.80 { 1.40%). The percentage of
M HCl for 20 min, washed in 0.1% diethylpyrocarbonate apoptotic neurons cultured in control SFDM con-
water (DEPC H2O), followed by PBS, and treated with taining 10 ng/mL NGF increased from 1.29
4 mg/mL proteinase K in a humid 507C oven for 30 min. { 0.61% at 12 h to 10.72 { 3.15% at 72 h. In
The reactions were stopped by two washes of PBS/SSC, contrast, the percentage of apoptotic neurons after
followed by fresh 0.1 M triethanolamine and acetic anhy- NGF withdrawal, but in the presence of IGF-I (Fig.
dride. After further washing in SCC, the tissues were 1) , was essentially unchanged or slightly reduced
incubated in prehybridization buffer at 507C, and then after 72 h. At 72 h, the percentage of apoptotic
hybridization performed in a humid 507C oven using di-
neurons was 5.10 { 0.95 for 1 nM IGF-I and 1.93goxigenin-labeled IGF-I receptor probes. Equal total con-
{ 0.73 for 100 nM IGF-I. At all time periods includ-centrations of sense and antisense RNA probes were used
ing 72 h, the percentage of apoptotic neurons in theon each tissue section. The digoxigenin-labeled human
presence of IGF-I alone was dose dependent. At 12or rat IGF-I receptor RNA probes were prepared as out-
h, the percentage of apoptotic neurons in controllined in the manufacturer’s recommendations (Boeh-
medium containing NGF was 8% less than withringer Mannheim, Mannheim, Germany) and as pre-
viously described (Leventhal et al., 1995; Werner et al., 1 nM IGF-I alone (Fig. 1) , and was significantly
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DRG neurons had undergone apoptosis [Fig.
2 (A)] . IGF-I inhibited apoptosis after NGF with-
drawal in a dose-dependent fashion in that the
percentage of apoptotic neurons decreased from
14% with 1 nM IGF-I to 7.6% with 10 nM IGF-
I, and 1.4% with 100 nM IGF-I [Fig. 2 (B) ] . The
percentage of apoptotic neurons was significantly
different with 1 nM IGF-I alone compared to 10
nM IGF-I alone (p õ .01) and 100 nM IGF-I ( p
Figure 1 IGF-I prevents apoptosis in rat DRG neurons
after NGF withdrawal. DRG neurons were cultured up
to 72 h in SFDM containing 10 ng/mL NGF (control) ,
no NGF with 10 mg/mL anti-NGF Ab, and 1–100 nM
IGF with 10 mg/mL anti-NGF Ab. After NGF with-
drawal, the percentage of apoptotic neurons increased up
to 72 h, with most of the neurons dying by 48 h. In the
presence of 100 nM IGF-I, õ5% apoptotic neurons were
seen at 72 h, less than in control neurons with NGF (p
õ .05) . Neuronal survival in the presence of IGF-I alone,
even at low concentrations (1 nM) , at 12–72 h was
statistically different from neurons in which NGF was
withdrawn (p õ .001).
different from 1 nM IGF-I (p õ .05) . However, at
12 h, there was no difference in the percentage of
apoptotic cells in control medium containing NGF
compared to medium containing 10 or 100 nM IGF-
I, although there was a significant difference be-
tween 1 and 10 or 100 nM IGF-I (p õ .05) . In
contrast, by 24 h, there was no statistical difference
between the percent apoptotic neurons with control
medium containing NGF and medium containing 1 Figure 2 IGF-I prevents apoptosis of rat DRG neurons
nM IGF-I (Fig. 1) . after NGF withdrawal at 48 h. (A) DRG neurons were
When combined NGF/IGF-I and IGF-I alone cultured for 48 h in SFDM with 10 ng/mL NGF, without
were compared, we found that at 12 h there was NGF, and with NGF and 1–100 nM IGF-I combined.
0.81 { 0.29% apoptotic neurons with 10 ng/mL (B) DRG neurons cultured as above with 1–100 nM
IGF-I alone. Condition 1 and 2 are the same in (A) andNGF and 1 nM IGF-I compared to 9.83 { 3.08%
(B). In the absence of NGF,ú95% of neurons were deadwith 1 nM IGF-I alone. However by 24 h, combined
at 48 h. The percentage of apoptotic neurons was reducedNGF and 1 nM IGF-I, or NGF and ¢10 nM IGF-
by the addition of 1 nM IGF-I to 14% (p õ .0001), andI at any time point (data not shown) did not further
the number of apoptotic neurons was further reduced insignificantly decrease the percentage of apoptotic
a dose-dependent manner to 7.6% with 10 nM IGF-I, andneurons, suggesting that the antiapoptotic effects of
1.4% with 100 nM IGF-I. Although there was a slight
NGF and IGF-I are not additive. decrease in the percentage of apoptotic neurons when
Dorsal root ganglion neurons were cultured in NGF was combined with IGF-I, there was no statistical
SFDM/FUDR as above, NGF were withdrawn, significance between neurons treated with IGF-I alone
10 mg/mL NGF antibody was added, and then test compared to NGF and IGF-I. The values are representa-
medium was added for 48 h (Fig. 2 ) . Under these tive of the mean of three separate experiments, standard-
ized against control values.conditions, we found that most NGF deprived
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õ .01) , consistent with a dose-dependent increase
in IGF-I neuroprotection against apoptosis after
NGF withdrawal. In the presence of 100 nM IGF-
I alone [Fig. 2 (B) ] , the percentage of apoptotic
neurons was significantly less than in control me-
dium with NGF (p õ .05) .
In a separate set of experiments, NGF was
withdrawn or IGF-I added from culture day 1 in-
stead of culture day 6. No anti-NGF antibody was
used in these experiments, but cultures were pre-
plated to remove contaminating Schwann cells
and fibroblasts. In these shorter-term experiments,
at 48 h the percentage of apoptosis in control neu-
rons (15.85 { 5.33%) was slightly higher than
longer-term cultures, but 100 nM IGF-I alone
with no NGF still reduced the percentage of
apoptosis to 6.77 { 2.90%. As with the longer-
term cultures described above, IGF-I was neuro-
protective in a dose-dependent manner after NGF
withdrawal, and there was no additive effect with
NGF and IGF-I combined (data not shown) .
Thus, although apoptosis was greater in controls
in the first 2 days in culture compared to that after
1 week in culture, the neuroprotective effect of
IGF-I was similar.
The classical changes of apoptosis were ob-
served in DRG neurons after NGF withdrawal.
Neurons were cultured in SFDM/FUDR for 48 h
after preplating, and then test medium was added
for 48 h. Anti-NGF antibody (10 mg/mL) was Figure 3 TEM of in vitro rat DRG at 48 h showing
neuronal rescue by IGF-I in the absence of NGF. (A)added in addition to NGF withdrawal. Condensa-
Control DRG with 10 ng/mL NGF showing normal chro-tion of the nuclear chromatin into apoptotic bod-
matin staining in the nucleus (N), and an intact perikar-ies, and shrinkage of the nucleus and cytoplasm,
yon. The neuroblast was encased in satellite cells (S).but preservation of the cytoplasmic membrane
(B) DRG after 48 h NGF withdrawal. There was severewere observed. At 48 h, almost all neurons
chromatin clumping (Ch) observed in the nucleus,
showed evidence of apoptosis, and there was sin-
shrinkage of the perikaryon—although at higher magni-
gle deletion of DRG neurons with preservation of fication the plasma membrane remained intact—and sin-
surrounding satellite cells and Schwann cells gle deletion of cells. At 48 h, most of the neuroblasts
[Fig. 3 ( B) ] . With IGF-I alone [Fig. 3 (C,D)] , were apoptotic. There was also a prominent collection of
there was sparing of neurons. Although with 1 nM lipofusion (white arrow) commonly observed in apo-
IGF-I the neuronal nucleus [Fig. 3 (C) ] showed ptotic DRG neurons. The satellite cells (S) were histolog-
ically unaffected by the NGF withdrawal. (C) DRGnormal chromatin distribution, there was evidence
with 1 nM IGF-I, but no NGF. The presence of IGF-Iof minimal perikaryeal shrinkage. With low-dose
supported neuronal survival as indicated, although severalIGF-I, some of the neurons continued to classical
neuroblasts continued to undergo apoptosis at this lowchanges of apoptosis, whereas with high-dose
concentration of IGF-I. (D) DRG with 100 nM IGF-I.IGF-I (100 nM ) , most of the DRG neurons were
There was survival of most of the neuroblasts, with nor-
morphologically normal with TEM. With com-
mal chromatin distribution in the nucleus (N). The nor-
bined NGF and IGF-I [Fig. 3 (E,F) ] , both DRG mal neuronal perikaryon was surrounded by satellite cells
neurons and satellite cells were morphologically (S). (E) DRG with 1 nM IGF-I and 10 ng/mL NGF.
normal. With NGF and 1 n M IGF-I, neuronal peri- (F) DRG with 100 nM IGF-I and 10 ng/mL NGF. In
karya were less likely to show early apoptotic both (E) and (F), the neuronal nuclei (N) were normal.
changes compared to 1 n M IGF-I alone, but no Apoptotic neurons were rare in the presence of both NGF
and IGF-I, and survival was slightly greater than controlsdifference was seen with 100 nM IGF-I compared
at higher concentrations of IGF-I.to NGF and 100 nM IGF-I.
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Table 1 IGF-I and Neuronal Cell Death
Condition % Apoptosis S.E.M. Condition % Apoptosis S.E.M.
NGF 10 ng/mL 8.82 3.50 LY294002 / IGF-I 99.20 0.25
No NGF 95.40 2.40 PD98059 / IGF-I 3.40 0.58
IGF-I 100 nM 0.22 0.11 BAF 0.34 0.19
BAF / IGF-I 0.38 0.35
NGF: nerve growth factor; IGF-I: insulin-like growth factor I; LY294002: PI 3-kinase inhibitor; PD98059: MAP kinase inhibitor;
BAF: Boc-aspartyl (OMe)-fluoromethylketone, a caspase inhibitor; S.E.M.: standard error of the mean.
IGF-I Prevents Neuronal Apoptosis after ent from IGF-I alone or BAF alone. Apoptosis was
less completely blocked by 10 mM BAF (data notNGF Withdrawal by Activation
of PI 3-Kinase Signaling shown).
The neuroprotective effect of IGF-I after NGF with-
drawal was blocked by 10 mM LY294002, an inhibi- IGF-I Receptor Distribution in Rat
tor of PI 3-kinase (Table 1). Since LY294002 will and Human DRG
also potentially block NGF-induced PI 3-kinase sig-
Dorsal root ganglion neurons were found to expressnaling, we examined whether LY294002 would
functional IGF-I receptor during development (E15block PI-3 kinase signaling induced specifically by
rat) and also in the adult human using both RT-IGF-I alone. In the presence of 100 nM IGF-I alone,
PCR and in situ hybridization techniques (Figs. 4most neurons survived NGF withdrawal at 48 h.
and 5). The sizes of the PCR products for humanHowever with 10 mM LY294002 and 100 nM IGF-
and rat IGF-I receptor were, respectively, 600 andI, 99% of neurons were dead at 48 h (p õ .0001).
933 bp. Specificity was confirmed by sequencingIn the presence of 10 mM PD98059, an inhibitor of
the PCR products and finding 98% homology withMAP-kinase/MEK signaling, 100 nM IGF-I still
predicted sequences (Werner et al., 1989; Ullrichreduced the percentage of apoptotic neurons to be-
et al., 1986). Using immunohistochemistry with an-low control levels (p õ .05) , although IGF-I and
tibody specific for the IGF-I receptor, we demon-PD98059 were slightly less neuroprotective than
strated that the IGF-I receptor was abundantly dis-IGF-I alone (not statistically significant) . Similar
tributed throughout the DRG neuron [Fig. 5(A)] .results were obtained whether or not anti-NGF anti-
With confocal microscopy and z-series resolutionbody was present in test medium. We had pre-
of the three-dimensional structure of the neuron, weviously shown in neurons that concentrations of
PD98059 ú10 mm had no appreciable additive ef-
fect in blocking the dual-specificity protein kinase
MEK (Kim et al., 1997), and in preliminary data
did not further block MAP kinase signaling in DRG
neurons.
Inhibition of the Caspase PCD Pathways
Inhibits Apoptosis Induced
by NGF Withdrawal
Inhibition of caspase cleavage by BAF (100 mM)
Figure 4 RT-PCR analysis of RNA transcripts usingalmost completely blocked apoptosis induced by
primers from IGF-I receptor in E15 embryonic rat DRGNGF withdrawal at 24 and 48 h. When DRG neu-
neurons (A) and human DRG neurons (B). (A) Ratrons were cultured for 5 days in NGF, BAF was
DRG: Lane 1 contains a 123-base pair (bp) DNA ladder,added, NGF was withdrawn and 10 mg/mL anti-
and lane 2, an RT-PCR product from IGF-I receptor
NGF antibody was added, the percentage of apo- mRNA; lane 3, a Ban1 digest of lane 2 product yielding
ptotic neurons was 0.34 { 0.19% compared to 8.82 predicted 246- and 684-bp products. (B) Human DRG:
{ 3.50% control neurons (põ .05) . The percentage Lane 1 contains a 123-bp DNA ladder; a 600-bp RT-
of apoptotic neurons could not be further decreased PCR fragment from adult human mRNA is seen in lanes
by the addition of 100 nM IGF-I to 100 mM BAF, 2 and 3 (two separate samples) . Equal levels of b-actin
were identified in each of the RT-PCR samples.and results were not statistically significantly differ-
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Figure 5 IGF-I receptor expression in the rat DRG neurite growth cone and in human DRG.
(A) The IGF-I receptor (white arrows) was abundant in the rat neurite growth cone. Rat DRG
were incubated with chicken IGF-IR IgY and viewed using confocal microscopy (11500). The
figure represents a z-series reconstruction of several image planes from the upper to the lower
surface of the neurite growth cone. The IGF-I receptor was distributed throughout the neuron,
but was most abundant in the DRG growth cone. (B) Image from an upper plane from the
z-series described in (A). The image plane was adjusted to lie just below the upper surface
of the neuron. Although the outline of the growth cone is seen, there are few IGF-I receptors
present. (C) Image from a lower plane (adjacent to the ECM) of the z-series described in
(A). More numerous IGF-I receptor staining (white arrows) is observed throughout the growth
cone. (D) In situ hybridization for IGF-I receptor in human DRG using antisense probe
showing abundant punctate labeling of IGF-I receptor mRNA (white arrows) throughout the
neuronal perikaryon (1500). N Å DRG neuronal nucleus. There was less abundant labeling
of satellite cells and fibroblasts. (E) Sense control showing no labeling of the neuron or
supporting cells (1500). N Å DRG neuronal nucleus. Equal total concentrations of sense and
antisense RNA probes were used on each tissue section.
found that the IGF-I receptor was mainly distributed the surface of the neuron in contact with the extra-
cellular matrix (ECM), although the IGF-I receptornear the surface of the neuron, was more abundant
in the region of the neurite growth cone, and ex- could be demonstrated throughout the neuron.
In human DRG, in situ hybridization using spe-tended out to the outer edges of the developing
lamellipodia [Fig. 5(A)] . Using z-series recon- cific RNA probes to human IGF-I receptor mRNA
developed with antidigoxigenin antibody showedstruction, the receptor distribution was greater on
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abundant signal throughout the neuronal cytoplasm had no additional antiapoptotic effect, suggesting
that NGF and IGF-I do not necessarily act additivelyand was not localized to a specific region of the
perikaryon [Fig. 5(B)] . The signal was likely spe- in inhibiting PCD. When IGF-I is used in vitro, as
with neurotrophic factors such as NGF (Russell etcific as indicated by the absence of signal to labeled
sense RNA probes [Fig. 5(C)] . In rat DRG, IGF- al., 1994), the concentration of IGF-I required to
promote a maximum biological effect is oftenI receptor mRNA was similarly widely distributed
throughout the neuronal perikaryon (data not greatly in excess of the receptor dissociation con-
stant for that factor. Although an almost maximalshown). In adult human DRG, IGF-I receptor
mRNA was less abundant in satellite cells and fi- antiapoptotic response was seen with 10 nM IGF-
I, a small additive effect was achieved with 100broblasts.
nM IGF-I. These observations may relate to IGF-
binding proteins (IGFBPs) modulation of IGF-I
binding at the IGF-I receptor (see Jones and Clem-DISCUSSION
mons, 1995, for review), uptake and internalization
of IGF-I by the IGF-I receptor, or proteolysis ofIn this study, we examined the ability of IGF-I to
IGF-I within the culture system.prevent apoptosis in DRG neurons after NGF with-
Nerve growth factor withdrawal has been welldrawal. Apoptosis refers to the characteristic mor-
described as a model for PCD in sympathetic neu-phological changes observed in PCD, including de-
rons (see Deshmukh and Johnson, 1997, for re-letion of single cells, cell shrinkage, membrane
view), as well as early differentiating cerebellarblebbing, and compaction of chromatin (Kerr et al.,
granule neurons (Muller et al., 1997), developing1972; Majno and Joris, 1995; Raff, 1992). Similar
basal forebrain cholinergic neurons (Kew and So-to sympathetic neurons, when NGF was withdrawn
from DRG, the majority of neurons were committed froniew, 1997), and differentiated PC12 cells
(Tong et al., 1997). Recently, it has been shownto die by 24 h (Deckwerth and Johnson, 1993; Ed-
wards and Tolkovsky, 1994) and apoptosis was the that inhibition of trk A receptor tyrosine signaling
does not affect apoptosis occurring in axotomizedpredominant form of cell death (Edwards and Tol-
kovsky, 1994). Using TEM, we observed prominent mouse DRG and nerve stumps. Furthermore, addi-
tion of NGF did not reduce the percentage of apo-chromatin condensation of DRG neuronal nuclei,
shrinkage of the perikaryon, and retention of plasma ptotic neurons (Edstrom et al., 1997). This suggests
that NGF may have a more circumscribed role inmembrane. In addition, many of the apoptotic DRG
had more prominent accumulations of lipofuscin preventing PCD in DRG than initially proposed
(Lindsay, 1988), whereas other growth factors likegranules in the cytoplasm than control neurons, a
change that has been associated with aging and de- IGF-I may be important. In parallel with the current
studies, we (Matthews and Feldman, 1996; Russellgeneration of neurons (Kerezoudi et al., 1995; Sa-
saki et al., 1997). et al., 1996; Singleton et al., 1996a) and others
(Miller et al., 1997) also found that IGF-I preventsInsulin-like growth factor-I prevented apoptosis
in DRG sensory neurons for at least 72 h after NGF PCD owing to a variety of neurotoxic stimuli in
both transformed and primary neural cell lines.withdrawal. In the presence of high concentrations
of IGF-I, most of the DRG neurons had a normal Signaling through the PI 3-kinase pathway is im-
portant in the prevention of apoptosis by NGF (Yaohistological appearance on TEM, and even small
concentrations of IGF-I (1 nM) maintained viability and Cooper, 1995). We found that inhibition of PI
3-kinase signaling by LY294002 blocks the antiapop-of neurons in the absence of NGF. We also used
TdT-mediated dUTP-biotin nick end labeling (TU- totic effect of IGF-I after NGF withdrawal in sensory
neurons. In comparison, the MAP-kinase/ERK in-NEL) to quantitate the number of apoptotic neurons.
In these experiments, we took advantage of the fact hibitor PD98059 had little effect on neuronal
apoptosis within this paradigm. We and othersthat in our culture system we can study a nearly
pure neuronal population. Under these conditions, previously reported that PI 3-kinase signaling in
neuronal and nonneuronal cells is important forthe calculated percentage of apoptotic neurons cor-
responded with the histological findings on TEM. IGF-mediated inhibition of PCD from a variety of
proapoptotic stimuli including high glucose andIGF-I alone maintained neuron viability in the ab-
sence of NGF for periods of at least 72 h. Further- hyperosmolarity (Singleton et al., 1996a; Russell et
al., 1997; Párrizas et al., 1997; D’Mello et al., 1997;more, although neuron survival was improved
slightly by combining low-dose IGF-I with NGF, Kulik et al., 1997); in contrast, neurite outgrowth
in vitro requires signaling though the MAP-kinaseat higher concentrations of IGF-I concomitant NGF
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pathway (Kim et al., 1997). While our current and on the extracellular matrix surface of the growth
cone. Our results agree with previous work sug-past data suggest IGF-I mediates separable signaling
pathways effecting cell death, Párrizas et al. (1997) gesting the IGF-I receptor is more abundant in neu-
rons than in glia (Burgess et al., 1987) and at growthreported an additional role for MAP-kinase/ERK
signaling in IGF-I inhibition of apoptosis occurring cones within the brain (Mascotti et al., 1997). The
abundance of IGF-I receptor within the growth conein PC12 cells after NGF deprivation.
We have previously found that under conditions suggests a role for IGF-I in axonal adhesion and
structural rearrangement of the cytoskeleton. Weof hyperglycemic or hyperosmolar stress autophos-
phorylation of IGF-IR activates PI 3-kinase, which recently found that IGF-I promotes remodeling of
the actin cytoskeleton and formation of focal adhe-in turn up-regulates protein expression of the PCD
inhibitors bcl-2 and bcl-xL (Singleton et al., 1996a; sions via activation of PI-3 kinase (Leventhal et al.,
1997; Leventhal and Feldman, 1997). These dataRussell et al., 1997). These proteins determine
whether a ‘‘death switch’’ is activated. Once acti- are interesting in light of evidence suggesting an
association between PCD, cellular adhesion, and thevated, this switch turns on caspase-8 and other
downstream ced-3/interleukin-1b converting en- cytoskeleton (Malorni et al., 1995). Indeed, cells
denied anchorage undergo a form of PCD calledzyme (ICE)-like proteases, such as caspase-3 (pro-
Yama and pro-CPP32) (Chinnaiyan et al., 1996; ‘‘anoikis’’ (Frisch and Francis, 1994). Attachment
Singleton et al., 1996a; Russell et al., 1997). In per se is insufficient to prevent anoikis; what is
sympathetic neurons, NGF and inhibitors of the required is the tyrosine phosphorylation of kinases
ICE-like proteases block apoptosis at a similar time such as focal adhesion kinase (FAK) involved in
point (Deshmukh et al., 1996). The small, cell- cytoskeletal organization (Ruoslahti and Reed,
permeable, aspartate-containing ‘‘pan-caspase’’ in- 1994; Topper et al., 1995). Collectively, these find-
hibitor BAF (Deshmukh and Johnson, 1997) has ings suggest that the DRG IGF-I receptor may, in
been shown to inhibit cleavage of caspase-3 in vitro. addition to its effect on bcl/caspase signaling, pre-
This inhibitor contains sequences corresponding to vent PCD by promoting adhesion to the extracellu-
the aspartate-containing cleavage site of all cas- lar matrix and stabilization of the actin cytoskeleton.
pases. We found that BAF was able to almost com- In summary, the abundance of functional IGF-I
pletely block PCD in DRG neurons after NGF with- receptor both in embryonic DRG and adult human
drawal, an effect that was maintained for at least DRG suggests an important role for IGF-I in sen-
48 h. The degree of PCD inhibition by BAF was sory neurons. IGF-I’s primary effect on embryonic
similar to that observed with IGF-I alone, and com- DRG sensory neurons is inhibition of PCD after
bining IGF-I and BAF did not produce additive inhi- NGF withdrawal. Inhibition of PCD requires IGF-
bition of apoptosis. In agreement with our results, I directed signaling through the PI 3-kinase path-
two other peptide inhibitors of ICE, Ac-YVAD- way, but not through MAP kinase/ERK. Our re-
CHO and Ac-YVAD-CMK, are able to block PCD sults support a role for IGF-I in DRG embryogene-
in motor neurons deprived of trophic factors (Desh- sis, and suggest that IGF-I may afford a potential
mukh and Johnson, 1997). Collectively, these re- treatment for neurotoxic and traumatic neuropa-
sults, along with our previous observations on IGF- thies.
I–mediated inhibition of PCD (Russell et al., 1996,
1997; Singleton et al., 1996a), indicate that IGF-I,
like BAF, is able to inhibit activation of the caspase The authors thank Dr. Brenda Shiver, of Warner-Lam-
bert, Parke-Davis, for providing BAF; Dr. Peter Dyck,death cascade after NGF withdrawal. However, un-
of the Mayo Clinic and Foundation, for providing humanlike BAF, IGF-I interrupts cell death signaling well
DRG autopsy tissue; Bruce Donohoe, of University ofupstream of caspase activation (Russell et al., 1996,
Michigan Cell Biology Laboratory Core Facility, for as-1997; Singleton et al., 1996a).
sistance with TEM sections; Judy Boldt, for expert secre-The distribution of the IGF-I receptor has been
tarial assistance; Jim Beals, for photographic preparation;previously described both in vivo and in vitro within
Dr. David I. Yule and the Michigan Diabetes Research
the mammalian brain (Han et al., 1987) and in avian
and Training Center, for assistance with confocal micro-
brain and sensory ganglia (Holzenberger et al., scope imaging; and Louanne Gross, B.A., for assistance
1997). We found that both human and rat DRG with in situ hybridization. This work was supported by the
abundantly express IGF-I receptor mRNA through- Veterans Administration (JWR), NIH NS01938 (JWR),
out the DRG neuronal perikaryon. In vitro, the IGF- NIH NS14304 (AJW), NIH NS32843 (ELF), and grants
I receptor was present in rat sensory neurons, and from the Juvenile Diabetes Foundation (ELF) and the
American Diabetes Association (ELF).using confocal imaging appeared to be concentrated
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